Skip to main content
SpringerLink
Log in

Lung Transplantation for Chronic Lung Disease: Cardiac Considerations

  • Chapter
  • First Online:
Cardiac Considerations in Chronic Lung Disease

Part of the book series: Respiratory Medicine ((RM))

  • 467 Accesses

Abstract

Lung transplantation may be considered for patients with a variety of end-stage lung diseases. Improvements in surgical technique, peri-operative management, and immunosuppressive strategies have resulted in better long-term post-transplant outcomes. However, careful candidate selection, including a thorough assessment of cardiac function, is essential for optimizing the likelihood of survival while awaiting transplantation, and improving the chance of a successful outcome. This chapter will review some of the important cardiac considerations for candidates with end-stage lung disease, including coronary artery disease, diastolic dysfunction, atrial arrhythmias, valvular heart disease, and pulmonary hypertension related to lung disease.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Chambers DC, Yusen RD, Cherikh WS, et al. The Registry of the International Society for Heart and Lung Transplantation: thirty-fourth adult lung and heart-lung transplantation report-2017; focus theme: allograft ischemic time. J Heart Lung Transplant. 2017;36:1047–59.

    Article  PubMed  Google Scholar 

  2. Verleden SE, Todd JL, Sato M, et al. Impact of CLAD phenotype on survival after lung retransplantation: a multicenter study. Am J Transplant. 2015;15:2223–30.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Maurer JR, Frost AE, Estenne M, Higenbottam T, Glanville AR. International guidelines for the selection of lung transplant candidates. The International Society for Heart and Lung Transplantation, the American Thoracic Society, the American Society of Transplant Physicians, the European Respiratory Society. J Heart Lung Transplant. 1998;17:703–9.

    CAS  PubMed  Google Scholar 

  4. Orens JB, Estenne M, Arcasoy S, et al. International guidelines for the selection of lung transplant candidates: 2006 update–a consensus report from the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant. 2006;25:745–55.

    Article  PubMed  Google Scholar 

  5. Weill D, Benden C, Corris PA, et al. A consensus document for the selection of lung transplant candidates: 2014–an update from the Pulmonary Transplantation Council of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant. 2015;34:1–15.

    Article  PubMed  Google Scholar 

  6. Benza RL, Miller DP, Frost A, Barst RJ, Krichman AM, McGoon MD. Analysis of the lung allocation score estimation of risk of death in patients with pulmonary arterial hypertension using data from the REVEAL Registry. Transplantation. 2010;90:298–305.

    Article  PubMed  Google Scholar 

  7. Benza RL, Miller DP, Gomberg-Maitland M, et al. Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL). Circulation. 2010;122:164–72.

    Article  PubMed  Google Scholar 

  8. Miller DP, Farber HW. “Who’ll be the next in line?” The lung allocation score in patients with pulmonary arterial hypertension. J Heart Lung Transplant. 2013;32:1165–7.

    Article  PubMed  Google Scholar 

  9. Liu Y, Vela M, Rudakevych T, Wigfield C, Garrity E, Saunders MR. Patient factors associated with lung transplant referral and waitlist for patients with cystic fibrosis and pulmonary fibrosis. J Heart Lung Transplant. 2017;36:264–71.

    Article  PubMed  Google Scholar 

  10. Vogl M, Warnecke G, Haverich A, et al. Lung transplantation in the spotlight: reasons for high-cost procedures. J Heart Lung Transplant. 2016;35:1227–36.

    Article  PubMed  Google Scholar 

  11. Verleden GM, Dupont L, Yserbyt J, et al. Recipient selection process and listing for lung transplantation. J Thorac Dis. 2017;9:3372–84.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Collaud S, Benden C, Ganter C, et al. Extracorporeal life support as bridge to lung retransplantation: a multicenter pooled data analysis. Ann Thorac Surg. 2016;102:1680–6.

    Article  PubMed  Google Scholar 

  13. Hayes D Jr, Higgins RS, Kilic A, et al. Extracorporeal membrane oxygenation and retransplantation in lung transplantation: an analysis of the UNOS registry. Lung. 2014;192:571–6.

    Article  CAS  PubMed  Google Scholar 

  14. Kawut SM. Lung retransplantation. Clin Chest Med. 2011;32:367–77.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Ren D, Kaleekal TS, Graviss EA, et al. Retransplantation outcomes at a large lung transplantation program. Transplant Direct. 2018;4:e404.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Revilla-Lopez E, Berastegui C, Saez-Gimenez B, et al. Lung retransplantation due to chronic lung allograph dysfunction: results from a Spanish transplant unit. Arch Bronconeumol. 2019;55:134–8.

    Article  PubMed  Google Scholar 

  17. Thomas M, Belli EV, Rawal B, Agnew RC, Landolfo KP. Survival after lung retransplantation in the United States in the current era (2004 to 2013): better or worse? Ann Thorac Surg. 2015;100:452–7.

    Article  PubMed  Google Scholar 

  18. Waseda R, Benazzo A, Hoetzenecker K, et al. The influence of retransplantation on survival for pediatric lung transplant recipients. J Thorac Cardiovasc Surg. 2018;156:2025–34. e2.

    Article  PubMed  Google Scholar 

  19. Smilowitz NR, Guo Y, Rao S, Gelb B, Berger JS, Bangalore S. Perioperative cardiovascular outcomes of non-cardiac solid organ transplant surgery. Eur Heart J Qual Care Clin Outcomes. 2019;5:72–8.

    Article  PubMed  Google Scholar 

  20. Smith SC Jr, Dove JT, Jacobs AK, et al. ACC/AHA guidelines for percutaneous coronary intervention (revision of the 1993 PTCA guidelines)-executive summary: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee to revise the 1993 guidelines for percutaneous transluminal coronary angioplasty) endorsed by the Society for Cardiac Angiography and Interventions. Circulation. 2001;103:3019–41.

    Article  PubMed  Google Scholar 

  21. Lentine KL, Costa SP, Weir MR, et al. Cardiac disease evaluation and management among kidney and liver transplantation candidates: a scientific statement from the American Heart Association and the American College of Cardiology Foundation: endorsed by the American Society of Transplant Surgeons, American Society of Transplantation, and National Kidney Foundation. Circulation. 2012;126:617–63.

    Article  PubMed  Google Scholar 

  22. Ben-Dor I, Shitrit D, Kramer MR, Iakobishvili Z, Sahar G, Hasdai D. Is routine coronary angiography and revascularization indicated among patients undergoing evaluation for lung transplantation? Chest. 2005;128:2557–62.

    Article  PubMed  Google Scholar 

  23. Jones RM, Enfield KB, Mehrad B, Keeley EC. Prevalence of obstructive coronary artery disease in patients undergoing lung transplantation: case series and review of the literature. Catheter Cardiovasc Interv. 2014;84:1–6.

    Article  PubMed  Google Scholar 

  24. Kaza AK, Dietz JF, Kern JA, et al. Coronary risk stratification in patients with end-stage lung disease. J Heart Lung Transplant. 2002;21:334–9.

    Article  PubMed  Google Scholar 

  25. Patel VS, Palmer SM, Messier RH, Davis RD. Clinical outcome after coronary artery revascularization and lung transplantation. Ann Thorac Surg. 2003;75:372–7; discussion 7.

    Article  PubMed  Google Scholar 

  26. Reed RM, Eberlein M, Girgis RE, et al. Coronary artery disease is under-diagnosed and under-treated in advanced lung disease. Am J Med. 2012;125:1228. e13–e22.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Seoane L, Arcement LM, Valentine VG, McFadden PM. Long-term survival in lung transplant recipients after successful preoperative coronary revascularization. J Thorac Cardiovasc Surg. 2005;130:538–41.

    Article  PubMed  Google Scholar 

  28. Schouten O, van Kuijk JP, Flu WJ, et al. Long-term outcome of prophylactic coronary revascularization in cardiac high-risk patients undergoing major vascular surgery (from the randomized DECREASE-V Pilot Study). Am J Cardiol. 2009;103:897–901.

    Article  PubMed  Google Scholar 

  29. Huiart L, Ernst P, Suissa S. Cardiovascular morbidity and mortality in COPD. Chest. 2005;128:2640–6.

    Article  PubMed  Google Scholar 

  30. Makey IA, Sui JW, Huynh C, Das NA, Thomas M, Johnson S. Lung transplant patients with coronary artery disease rarely die of cardiac causes. Clin Transpl. 2018;32:e13354.

    Article  Google Scholar 

  31. Sidney S, Sorel M, Quesenberry CP Jr, DeLuise C, Lanes S, Eisner MD. COPD and incident cardiovascular disease hospitalizations and mortality: Kaiser Permanente Medical Care Program. Chest. 2005;128:2068–75.

    Article  PubMed  Google Scholar 

  32. Kizer JR, Zisman DA, Blumenthal NP, et al. Association between pulmonary fibrosis and coronary artery disease. Arch Intern Med. 2004;164:551–6.

    Article  PubMed  Google Scholar 

  33. Snell GI, Richardson M, Griffiths AP, Williams TJ, Esmore DS. Coronary artery disease in potential lung transplant recipients > 50 years old: the role of coronary intervention. Chest. 1999;116:874–9.

    Article  CAS  PubMed  Google Scholar 

  34. Koprivanac M, Budev MM, Yun JJ, et al. How important is coronary artery disease when considering lung transplant candidates? J Heart Lung Transplant. 2016;35:1453–61.

    Article  PubMed  Google Scholar 

  35. Halloran K, Hirji A, Li D, et al. Coronary artery disease and coronary artery bypass grafting at the time of lung transplantation do not impact overall survival. Transplantation. 2019;103(10):2190–5.

    Article  PubMed  Google Scholar 

  36. McKellar SH, Bowen ME, Baird BC, Raman S, Cahill BC, Selzman CH. Lung transplantation following coronary artery bypass surgery-improved outcomes following single-lung transplant. J Heart Lung Transplant. 2016;35:1289–94.

    Article  PubMed  Google Scholar 

  37. Budoff MJ, Achenbach S, Blumenthal RS, et al. Assessment of coronary artery disease by cardiac computed tomography: a scientific statement from the American Heart Association Committee on Cardiovascular Imaging and Intervention, Council on Cardiovascular Radiology and Intervention, and Committee on Cardiac Imaging, Council on Clinical Cardiology. Circulation. 2006;114:1761–91.

    Article  PubMed  Google Scholar 

  38. Ali A, Bhardwaj HL, Heuman DM, Jovin IS. Coronary events in patients undergoing orthotopic liver transplantation: perioperative evaluation and management. Clin Transpl. 2013;27:E207–15.

    Article  Google Scholar 

  39. Ehtisham J, Altieri M, Salame E, Saloux E, Ollivier I, Hamon M. Coronary artery disease in orthotopic liver transplantation: pretransplant assessment and management. Liver Transpl. 2010;16:550–7.

    Article  PubMed  Google Scholar 

  40. Bermudez CA, Rocha RV, Zaldonis D, et al. Extracorporeal membrane oxygenation as a bridge to lung transplant: midterm outcomes. Ann Thorac Surg. 2011;92:1226–31; discussion 31–2.

    Article  PubMed  Google Scholar 

  41. Hoetzenecker K, Donahoe L, Yeung JC, et al. Extracorporeal life support as a bridge to lung transplantation-experience of a high-volume transplant center. J Thorac Cardiovasc Surg. 2018;155:1316–28. e1.

    Article  PubMed  Google Scholar 

  42. Kearns SK, Hernandez OO. “Awake” extracorporeal membrane oxygenation as a bridge to lung transplant. AACN Adv Crit Care. 2016;27:293–300.

    Article  PubMed  Google Scholar 

  43. Sharma NS, Hartwig MG, Hayes D Jr. Extracorporeal membrane oxygenation in the pre and post lung transplant period. Ann Transl Med. 2017;5:74.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  44. Spinelli E, Protti A. Get fit for lung transplant with ambulatory extracorporeal membrane oxygenation! Respir Care. 2016;61:117–8.

    Article  PubMed  Google Scholar 

  45. van Berkel V. Yesterday’s heroic measure is now standard procedure: extracorporeal membrane oxygenation as a bridge to lung transplant. J Thorac Cardiovasc Surg. 2018;155:1314–5.

    Article  PubMed  Google Scholar 

  46. Garcia JP, Kon ZN, Evans C, et al. Ambulatory veno-venous extracorporeal membrane oxygenation: innovation and pitfalls. J Thorac Cardiovasc Surg. 2011;142:755–61.

    Article  PubMed  Google Scholar 

  47. Hayes D Jr, Kukreja J, Tobias JD, Ballard HO, Hoopes CW. Ambulatory venovenous extracorporeal respiratory support as a bridge for cystic fibrosis patients to emergent lung transplantation. J Cyst Fibros. 2012;11:40–5.

    Article  PubMed  Google Scholar 

  48. Jacob S, MacHannaford JC, Chamogeorgakis T, et al. Ambulatory extracorporeal membrane oxygenation with subclavian venoarterial cannulation to increase mobility and recovery in a patient awaiting cardiac transplantation. Proc (Bayl Univ Med Cent). 2017;30:224–5.

    Article  Google Scholar 

  49. Lehr CJ, Zaas DW, Cheifetz IM, Turner DA. Ambulatory extracorporeal membrane oxygenation as a bridge to lung transplantation: walking while waiting. Chest. 2015;147:1213–8.

    Article  PubMed  Google Scholar 

  50. Lindholm JA. Ambulatory veno-venous extracorporeal membrane oxygenation. J Thorac Dis. 2018;10:S670–S3.

    Article  PubMed  PubMed Central  Google Scholar 

  51. Wong JY, Buchholz H, Ryerson L, et al. Successful semi-ambulatory veno-arterial extracorporeal membrane oxygenation bridge to heart-lung transplantation in a very small child. Am J Transplant. 2015;15:2256–60.

    Article  CAS  PubMed  Google Scholar 

  52. Abrams D, Garan AR, Brodie D. Awake and fully mobile patients on cardiac extracorporeal life support. Ann Cardiothorac Surg. 2019;8:44–53.

    Article  PubMed  PubMed Central  Google Scholar 

  53. desJardins SE, Crowley DC, Beekman RH, Lloyd TR. Utility of cardiac catheterization in pediatric cardiac patients on ECMO. Catheter Cardiovasc Interv. 1999;46:62–7.

    Article  CAS  PubMed  Google Scholar 

  54. Guzeltas A, Kasar T, Tanidir IC, Ozturk E, Yildiz O, Haydin S. Cardiac catheterization procedures in pediatric patients undergoing extracorporeal membrane oxygenation cardiac catheterization, ECMO. Anatol J Cardiol. 2017;18:425–30.

    PubMed  PubMed Central  Google Scholar 

  55. Booth KL, Roth SJ, Perry SB, del Nido PJ, Wessel DL, Laussen PC. Cardiac catheterization of patients supported by extracorporeal membrane oxygenation. J Am Coll Cardiol. 2002;40:1681–6.

    Article  PubMed  Google Scholar 

  56. Boscamp NS, Turner ME, Crystal M, Anderson B, Vincent JA, Torres AJ. Cardiac catheterization in pediatric patients supported by extracorporeal membrane oxygenation: a 15-year experience. Pediatr Cardiol. 2017;38:332–7.

    Article  PubMed  Google Scholar 

  57. Burke CR, Chan T, Rubio AE, McMullan DM. Early cardiac catheterization leads to shortened pediatric extracorporeal membrane oxygenation run duration. J Interv Cardiol. 2017;30:170–6.

    Article  PubMed  Google Scholar 

  58. Callahan R, Trucco SM, Wearden PD, Beerman LB, Arora G, Kreutzer J. Outcomes of pediatric patients undergoing cardiac catheterization while on extracorporeal membrane oxygenation. Pediatr Cardiol. 2015;36:625–32.

    Article  PubMed  Google Scholar 

  59. Kato A, Lo Rito M, Lee KJ, et al. Impacts of early cardiac catheterization for children with congenital heart disease supported by extracorporeal membrane oxygenation. Catheter Cardiovasc Interv. 2017;89:898–905.

    Article  PubMed  Google Scholar 

  60. Guerrero-Miranda CY, Hall SA. Cardiac catheterization and percutaneous intervention procedures on extracorporeal membrane oxygenation support. Ann Cardiothorac Surg. 2019;8:123–8.

    Article  PubMed  PubMed Central  Google Scholar 

  61. Castleberry AW, Martin JT, Osho AA, et al. Coronary revascularization in lung transplant recipients with concomitant coronary artery disease. Am J Transplant. 2013;13:2978–88.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  62. Wild J, Arrigo M, Isenring BD, et al. Coronary artery disease in lung transplant candidates: role of routine invasive assessment. Respiration. 2015;89:107–11.

    Article  PubMed  Google Scholar 

  63. Capodanno D. Triple antithrombotic therapy after ACS and PCI in patients on chronic oral anticoagulation: update. Heart. 2018;104:1976.

    Article  CAS  PubMed  Google Scholar 

  64. Fluschnik N, Becher PM, Schnabel R, Blankenberg S, Westermann D. Anticoagulation strategies in patients with atrial fibrillation after PCI or with ACS: the end of triple therapy? Herz. 2018;43:20–5.

    Article  CAS  PubMed  Google Scholar 

  65. Giri J, Nathan A. Is it time to abandon dual antiplatelet therapy after percutaneous coronary intervention in patients with atrial fibrillation on anticoagulation? JACC Cardiovasc Interv. 2018;11:635–7.

    Article  PubMed  Google Scholar 

  66. Smith M, Wakam G, Wakefield T, Obi A. New trends in anticoagulation therapy. Surg Clin North Am. 2018;98:219–38.

    Article  PubMed  PubMed Central  Google Scholar 

  67. Webster E, Gil M. Advances in anticoagulation therapy. JAAPA. 2018;31:30–5.

    Article  PubMed  Google Scholar 

  68. Renner TA, Zalunardo MP, Weder W, Spahn DR. Bilateral lung transplantation in a patient receiving rivaroxaban anticoagulation. J Cardiothorac Vasc Anesth. 2015;29:723–6.

    Article  PubMed  Google Scholar 

  69. Lichvar AB, Moore CA, Ensor CR, McDyer JF, Teuteberg JJ, Shullo MA. Evaluation of direct oral anticoagulation therapy in heart and lung transplant recipients. Prog Transplant. 2016;26:263–9.

    Article  PubMed  Google Scholar 

  70. Howson JMM, Zhao W, Barnes DR, et al. Fifteen new risk loci for coronary artery disease highlight arterial-wall-specific mechanisms. Nat Genet. 2017;49:1113–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  71. Kato TS, Armstrong HF, Schulze PC, et al. Left and right ventricular functional dynamics determined by echocardiograms before and after lung transplantation. Am J Cardiol. 2015;116:652–9.

    Article  PubMed  PubMed Central  Google Scholar 

  72. Nowak J, Hudzik B, Niedziela JT, et al. The role of echocardiographic parameters in predicting survival of patients with lung diseases referred for lung transplantation. Clin Respir J. 2019;13:212.

    Article  PubMed  Google Scholar 

  73. Nowak J, Hudzik B, Przybylowski P, et al. Prognostic value of mean, diastolic, and systolic pulmonary artery pressure in patients with end-stage lung disease referred for lung transplantation. Transplant Proc. 2018;50:2048–52.

    Article  CAS  PubMed  Google Scholar 

  74. Porteous MK, Ky B, Kirkpatrick JN, et al. Diastolic dysfunction increases the risk of primary graft dysfunction after lung transplant. Am J Respir Crit Care Med. 2016;193:1392–400.

    Article  PubMed  PubMed Central  Google Scholar 

  75. Perez-Teran P, Roca O, Rodriguez-Palomares J, et al. Influence of right ventricular function on the development of primary graft dysfunction after lung transplantation. J Heart Lung Transplant. 2015;34:1423–9.

    Article  PubMed  Google Scholar 

  76. Li D, Weinkauf J, Hirji A, et al. Elevated pre-transplant left ventricular end-diastolic pressure increases primary graft dysfunction risk in double lung transplant recipients. J Heart Lung Transplant. 2019;38:710.

    Article  PubMed  Google Scholar 

  77. Avriel A, Klement AH, Johnson SR, de Perrot M, Granton J. Impact of left ventricular diastolic dysfunction on lung transplantation outcome in patients with pulmonary arterial hypertension. Am J Transplant. 2017;17:2705–11.

    Article  CAS  PubMed  Google Scholar 

  78. Yadlapati A, Lynch JP 3rd, Saggar R, et al. Preoperative cardiac variables of diastolic dysfunction and clinical outcomes in lung transplant recipients. J Transp Secur. 2013;2013:391620.

    Google Scholar 

  79. Heeringa J, van der Kuip DA, Hofman A, et al. Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study. Eur Heart J. 2006;27:949–53.

    Article  PubMed  Google Scholar 

  80. Bargehr J, Trejo-Gutierrez JF, Rosser BG, et al. Liver transplantation in patients with atrial fibrillation. Transplant Proc. 2013;45:2302–6.

    Article  CAS  PubMed  Google Scholar 

  81. Vannucci A, Rathor R, Vachharajani N, Chapman W, Kangrga I. Atrial fibrillation in patients undergoing liver transplantation-a single-center experience. Transplant Proc. 2014;46:1432–7.

    Article  CAS  PubMed  Google Scholar 

  82. Rogers CA, Angelini GD, Culliford LA, Capoun R, Ascione R. Coronary surgery in patients with preexisting chronic atrial fibrillation: early and midterm clinical outcome. Ann Thorac Surg. 2006;81:1676–82.

    Article  PubMed  Google Scholar 

  83. Wang TK, Ramanathan T, Choi DH, Gamble G, Ruygrok P. Preoperative atrial fibrillation predicts mortality and morbidity after aortic valve replacement. Interact Cardiovasc Thorac Surg. 2014;19:218–22.

    Article  PubMed  Google Scholar 

  84. Roukoz H, Benditt DG. Atrial arrhythmias after lung transplantation. Trends Cardiovasc Med. 2018;28:53–61.

    Article  PubMed  Google Scholar 

  85. Fan J, Zhou K, Li S, Du H, Che G. Incidence, risk factors and prognosis of postoperative atrial arrhythmias after lung transplantation: a systematic review and meta-analysis. Interact Cardiovasc Thorac Surg. 2016;23:790–9.

    Article  PubMed  Google Scholar 

  86. Orrego CM, Cordero-Reyes AM, Estep JD, et al. Atrial arrhythmias after lung transplant: underlying mechanisms, risk factors, and prognosis. J Heart Lung Transplant. 2014;33:734–40.

    Article  PubMed  Google Scholar 

  87. Chaikriangkrai K, Jyothula S, Jhun HY, et al. Incidence, risk factors, prognosis, and electrophysiological mechanisms of atrial arrhythmias after lung transplantation. JACC Clin Electrophysiol. 2015;1:296–305.

    Article  PubMed  PubMed Central  Google Scholar 

  88. D’Angelo AM, Chan EG, Hayanga JW, et al. Atrial arrhythmias after lung transplantation: incidence and risk factors in 652 lung transplant recipients. J Thorac Cardiovasc Surg. 2016;152:901–9.

    Article  PubMed  Google Scholar 

  89. Raghavan D, Gao A, Ahn C, et al. Contemporary analysis of incidence of post-operative atrial fibrillation, its predictors, and association with clinical outcomes in lung transplantation. J Heart Lung Transplant. 2015;34:563–70.

    Article  PubMed  Google Scholar 

  90. Henri C, Giraldeau G, Dorais M, et al. Atrial fibrillation after pulmonary transplantation: incidence, impact on mortality, treatment effectiveness, and risk factors. Circ Arrhythm Electrophysiol. 2012;5:61–7.

    Article  PubMed  Google Scholar 

  91. Waldron NH, Klinger RY, Hartwig MG, Snyder LD, Daubert JP, Mathew JP. Adverse outcomes associated with postoperative atrial arrhythmias after lung transplantation: a meta-analysis and systematic review of the literature. Clin Transpl. 2017;31(4):e12926.

    Article  Google Scholar 

  92. Saad M, Elgendy IY, Mentias A, et al. Incidence, predictors, and outcomes of early atrial arrhythmias after lung transplant: a systematic review and meta-analysis. JACC Clin Electrophysiol. 2017;3:718–26.

    Article  PubMed  Google Scholar 

  93. Yerasi C, Roy SB, Olson M, et al. Outcomes of lung transplant recipients with preoperative atrial fibrillation. Asian Cardiovasc Thorac Ann. 2018;26:127–32.

    Article  PubMed  Google Scholar 

  94. Osho AA, Castleberry AW, Yerokun BA, et al. Clinical predictors and outcome implications of early readmission in lung transplant recipients. J Heart Lung Transplant. 2017;36:546–53.

    Article  PubMed  Google Scholar 

  95. Malik A, Hsu JC, Hoopes C, Itinarelli G, Marcus GM. Elevated pulmonary artery systolic pressures are associated with a lower risk of atrial fibrillation following lung transplantation. J Electrocardiol. 2013;46:38–42.

    Article  PubMed  Google Scholar 

  96. Lee G, Wu H, Kalman JM, et al. Atrial fibrillation following lung transplantation: double but not single lung transplant is associated with long-term freedom from paroxysmal atrial fibrillation. Eur Heart J. 2010;31:2774–82.

    Article  PubMed  Google Scholar 

  97. Garcia S, Canoniero M, Sattiraju S, et al. Atrial fibrillation after lung transplantation: incidence, predictors and long-term implications. J Atr Fibrillation. 2011;4:363.

    PubMed  PubMed Central  Google Scholar 

  98. Jesel L, Barraud J, Lim HS, et al. Early and late atrial arrhythmias after lung transplantation- incidence, predictive factors and impact on mortality. Circ J. 2017;81:660–7.

    Article  PubMed  Google Scholar 

  99. Mason DP, Marsh DH, Alster JM, et al. Atrial fibrillation after lung transplantation: timing, risk factors, and treatment. Ann Thorac Surg. 2007;84:1878–84.

    Article  PubMed  Google Scholar 

  100. Bazaz R, Salizzoni S, Bonde P, Espinoza A, Toyoda Y. A novel strategy for prevention of post-operative atrial arrhythmias in patients undergoing lung transplantation. J Heart Lung Transplant. 2010;29:713–5.

    Article  PubMed  Google Scholar 

  101. Szeplaki G, Szegedi N, Tahin T, Merkely B, Geller L. Successful catheter ablation of right atrial tachycardia after bilateral lung transplantation. Transplantation. 2015;99:e115–6.

    Article  PubMed  PubMed Central  Google Scholar 

  102. Fournet D, Zimmermann M, Campanini C. Atrial tachycardia with recipient-to-donor atrioatrial conduction and isthmus-dependent donor atrial flutter in a patient after orthotopic heart transplantation. Successful treatment by radiofrequency catheter ablation. J Heart Lung Transplant. 2002;21:923–7.

    Article  PubMed  Google Scholar 

  103. Isiadinso I, Meshkov AB, Gaughan J, et al. Atrial arrhythmias after lung and heart-lung transplant: effects on short-term mortality and the influence of amiodarone. J Heart Lung Transplant. 2011;30:37–44.

    Article  PubMed  Google Scholar 

  104. Adegunsoye A, Strek ME, Garrity E, Guzy R, Bag R. Comprehensive care of the lung transplant patient. Chest. 2017;152:150–64.

    Article  PubMed  Google Scholar 

  105. Diaz-Guzman E, Mireles-Cabodevila E, Arrossi A, Kanne JP, Budev M. Amiodarone pulmonary toxicity after lung transplantation. J Heart Lung Transplant. 2008;27:1059–63.

    Article  PubMed  Google Scholar 

  106. Andersen KH, Iversen M, Kjaergaard J, et al. Prevalence, predictors, and survival in pulmonary hypertension related to end-stage chronic obstructive pulmonary disease. J Heart Lung Transplant. 2012;31:373–80.

    Article  PubMed  Google Scholar 

  107. Chaouat A, Bugnet AS, Kadaoui N, et al. Severe pulmonary hypertension and chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2005;172:189–94.

    Article  PubMed  Google Scholar 

  108. Hamada K, Nagai S, Tanaka S, et al. Significance of pulmonary arterial pressure and diffusion capacity of the lung as prognosticator in patients with idiopathic pulmonary fibrosis. Chest. 2007;131:650–6.

    Article  PubMed  Google Scholar 

  109. Kimura M, Taniguchi H, Kondoh Y, et al. Pulmonary hypertension as a prognostic indicator at the initial evaluation in idiopathic pulmonary fibrosis. Respiration. 2013;85:456–63.

    Article  PubMed  Google Scholar 

  110. Oswald-Mammosser M, Weitzenblum E, Quoix E, et al. Prognostic factors in COPD patients receiving long-term oxygen therapy. Importance of pulmonary artery pressure. Chest. 1995;107:1193–8.

    Article  CAS  PubMed  Google Scholar 

  111. Maher TM, Dejonckheere F, Nathan SD. Survival in idiopathic pulmonary fibrosis: perspectives from pulmonary arterial hypertension. J Manag Care Spec Pharm. 2017;23:S3–4.

    PubMed  Google Scholar 

  112. Nathan SD. Pulmonary hypertension complicating pulmonary fibrosis: bad and ugly, but good to treat? Thorax. 2014;69:107–8.

    Article  PubMed  Google Scholar 

  113. Nathan SD, Shlobin OA, Ahmad S, et al. Serial development of pulmonary hypertension in patients with idiopathic pulmonary fibrosis. Respiration. 2008;76:288–94.

    Article  CAS  PubMed  Google Scholar 

  114. Shorr AF, Wainright JL, Cors CS, Lettieri CJ, Nathan SD. Pulmonary hypertension in patients with pulmonary fibrosis awaiting lung transplant. Eur Respir J. 2007;30:715–21.

    Article  CAS  PubMed  Google Scholar 

  115. Kadikar A, Maurer J, Kesten S. The six-minute walk test: a guide to assessment for lung transplantation. J Heart Lung Transplant. 1997;16:313–9.

    CAS  PubMed  Google Scholar 

  116. Redelmeier DA, Bayoumi AM, Goldstein RS, Guyatt GH. Interpreting small differences in functional status: the Six Minute Walk test in chronic lung disease patients. Am J Respir Crit Care Med. 1997;155:1278–82.

    Article  CAS  PubMed  Google Scholar 

  117. Chetta A, Aiello M, Foresi A, et al. Relationship between outcome measures of six-minute walk test and baseline lung function in patients with interstitial lung disease. Sarcoidosis Vasc Diffuse Lung Dis. 2001;18:170–5.

    CAS  PubMed  Google Scholar 

  118. Holland AE, Hill CJ, Conron M, Munro P, McDonald CF. Small changes in six-minute walk distance are important in diffuse parenchymal lung disease. Respir Med. 2009;103:1430–5.

    Article  PubMed  Google Scholar 

  119. Demir R, Kucukoglu MS. Six-minute walk test in pulmonary arterial hypertension. Anatol J Cardiol. 2015;15:249–54.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  120. Souza R, Channick RN, Delcroix M, et al. Association between six-minute walk distance and long-term outcomes in patients with pulmonary arterial hypertension: data from the randomized SERAPHIN trial. PLoS One. 2018;13:e0193226.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  121. Golpe R, Castro-Anon O, Perez-de-Llano LA, et al. Prognostic significance of six-minute walk test in non-group 1 pulmonary hypertension. Heart Lung. 2014;43:72–6.

    Article  PubMed  Google Scholar 

  122. Gadre A, Ghattas C, Han X, Wang X, Minai O, Highland KB. Six-minute walk test as a predictor of diagnosis, disease severity, and clinical outcomes in scleroderma-associated pulmonary hypertension: the DIBOSA study. Lung. 2017;195:529–36.

    Article  PubMed  Google Scholar 

  123. Swigris JJ, Olson AL, Shlobin OA, Ahmad S, Brown KK, Nathan SD. Heart rate recovery after six-minute walk test predicts pulmonary hypertension in patients with idiopathic pulmonary fibrosis. Respirology. 2011;16:439–45.

    Article  PubMed  PubMed Central  Google Scholar 

  124. Ussavarungsi K, Lee AS, Burger CD. Can a six-minute walk distance predict right ventricular dysfunction in patients with diffuse parenchymal lung disease and pulmonary hypertension? Oman Med J. 2016;31:345–51.

    Article  PubMed  PubMed Central  Google Scholar 

  125. Donadio MV, Heinzmann-Filho JP, Vendrusculo FM, Frasson PXH, Marostica PJC. Six-minute walk test results predict risk of hospitalization for youths with cystic fibrosis: a 5-year follow-up study. J Pediatr. 2017;182:204–9. e1.

    Article  PubMed  Google Scholar 

  126. Malamud AL, Ricard PE. Feasibility of the six-minute walk test for patients who have cystic fibrosis, are ambulatory, and require mechanical ventilation before lung transplantation. Phys Ther. 2016;96:1468–76.

    Article  PubMed  Google Scholar 

  127. Martin C, Chapron J, Hubert D, et al. Prognostic value of six minute walk test in cystic fibrosis adults. Respir Med. 2013;107:1881–7.

    Article  PubMed  Google Scholar 

  128. Andrianopoulos V, Wouters EF, Pinto-Plata VM, et al. Prognostic value of variables derived from the six-minute walk test in patients with COPD: results from the ECLIPSE study. Respir Med. 2015;109:1138–46.

    Article  PubMed  Google Scholar 

  129. Brasil Santos D, de Assis Viegas CA. Correlation of levels of obstruction in COPD with lactate and six-minute walk test. Rev Port Pneumol. 2009;15:11–25.

    Article  PubMed  Google Scholar 

  130. Enfield K, Gammon S, Floyd J, et al. Six-minute walk distance in patients with severe end-stage COPD: association with survival after inpatient pulmonary rehabilitation. J Cardiopulm Rehabil Prev. 2010;30:195–202.

    Article  PubMed  PubMed Central  Google Scholar 

  131. Fujimoto H, Asai K, Watanabe T, Kanazawa H, Hirata K. Association of six-minute walk distance (6MWD) with resting pulmonary function in patients with chronic obstructive pulmonary disease (COPD). Osaka City Med J. 2011;57:21–9.

    PubMed  Google Scholar 

  132. Moreira MA, Medeiros GA, Boeno FP, Sanches PR, Silva Junior DP, Muller AF. Oxygen desaturation during the six-minute walk test in COPD patients. J Bras Pneumol. 2014;40:222–8.

    Article  PubMed  PubMed Central  Google Scholar 

  133. Porteous MK, Rivera-Lebron BN, Kreider M, Lee J, Kawut SM. Determinants of 6-minute walk distance in patients with idiopathic pulmonary fibrosis undergoing lung transplant evaluation. Pulm Circ. 2016;6:30–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  134. Yimlamai D, Freiberger DA, Gould A, Zhou J, Boyer D. Pretransplant six-minute walk test predicts peri- and post-operative outcomes after pediatric lung transplantation. Pediatr Transplant. 2013;17:34–40.

    Article  PubMed  Google Scholar 

  135. Castleberry AW, Englum BR, Snyder LD, et al. The utility of preoperative six-minute-walk distance in lung transplantation. Am J Respir Crit Care Med. 2015;192:843–52.

    Article  PubMed  PubMed Central  Google Scholar 

  136. Balci MK, Ari E, Vayvada M, et al. Assessment of pulmonary hypertension in lung transplantation candidates: correlation of doppler echocardiography with right heart catheterization. Transplant Proc. 2016;48:2797–802.

    Article  CAS  PubMed  Google Scholar 

  137. Nowak J, Hudzik B, Jastrze Bski D, et al. Pulmonary hypertension in advanced lung diseases: echocardiography as an important part of patient evaluation for lung transplantation. Clin Respir J. 2017;12(3):930–8.

    Article  PubMed  Google Scholar 

  138. Jose A, King CS, Shlobin OA, Brown AW, Wang C, Nathan SD. Exercise pulmonary haemodynamic response predicts outcomes in fibrotic lung disease. Eur Respir J. 2018;52:1801015.

    Article  PubMed  Google Scholar 

  139. Gupta S, Torres F, Bollineni S, Mohanka M, Kaza V. Left ventricular dysfunction after lung transplantation for pulmonary arterial hypertension. Transplant Proc. 2015;47:2732–6.

    Article  CAS  PubMed  Google Scholar 

  140. Andersen KH, Schultz HH, Nyholm B, Iversen MP, Gustafsson F, Carlsen J. Pulmonary hypertension as a risk factor of mortality after lung transplantation. Clin Transpl. 2016;30:357–64.

    Article  Google Scholar 

  141. McCartney SL, Cooter M, Samad Z, et al. Mitral regurgitation after orthotopic lung transplantation: natural history and impact on outcomes. J Cardiothorac Vasc Anesth. 2017;31:924–30.

    Article  PubMed  Google Scholar 

  142. Udoji TN, Force SD, Pelaez A. Severe mitral regurgitation unmasked after bilateral lung transplantation. Pulm Circ. 2013;3:696–9.

    Article  PubMed  PubMed Central  Google Scholar 

  143. Banack T, Ziganshin BA, Barash P, Elefteriades JA. Aortic valve replacement for critical aortic stenosis after bilateral lung transplantation. Ann Thorac Surg. 2013;96:1475–8.

    Article  PubMed  Google Scholar 

  144. Brill AK, Gloekler S, Aubert JD, Wenaweser PM, Geiser T. Transcatheter aortic valve implantation in a lung transplant recipient. Ann Thorac Surg. 2014;97:e159–60.

    Article  PubMed  Google Scholar 

  145. Sugizaki Y, Mori S, Nagamatsu Y, et al. Critical exacerbation of idiopathic pulmonary fibrosis after transcatheter aortic valve implantation: need for multidisciplinary care beyond “heart team”. J Cardiol Cases. 2018;18:171–4.

    Article  PubMed  PubMed Central  Google Scholar 

  146. Lazaro M, Ramos A, Ussetti P, et al. Aspergillus endocarditis in lung transplant recipients: case report and literature review. Transpl Infect Dis. 2011;13:186–91.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA

    Keith M. Wille & Victoria Rusanov

  2. Louisiana State University, Baton Rouge, LA, USA

    Tyler R. Reynolds

Authors
  1. Keith M. Wille
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Tyler R. Reynolds
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Victoria Rusanov
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Keith M. Wille .

Editor information

Editors and Affiliations

  1. Division of Pulmonary, Allergy and Critical Care Medicine, University of Alabama at Birmingham, Birmingham, AL, USA

    Surya P. Bhatt

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Wille, K.M., Reynolds, T.R., Rusanov, V. (2020). Lung Transplantation for Chronic Lung Disease: Cardiac Considerations. In: Bhatt, S. (eds) Cardiac Considerations in Chronic Lung Disease. Respiratory Medicine. Humana, Cham. https://doi.org/10.1007/978-3-030-43435-9_13

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-43435-9_13

  • Published:

  • Publisher Name: Humana, Cham

  • Print ISBN: 978-3-030-43434-2

  • Online ISBN: 978-3-030-43435-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation